Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP100399

Drug Information
NameDoxycycline
SynonymsVibramycin Novum; Spectrum2_000143; DivK1c_000345; CHEBI:50845; NSC633557; Doxycycline (INN); 6-Deoxyoxytetracycline; Doxycyclin; AC1O8PYM; alpha-Doxycycline; 94088-85-4 (calcium salt (1:2)); 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)-; 7264-10-0; DOXYCYCLINE MONOHYDRATE; Hydramycin; Doxitard; Doxycyclinum; KBioGR_001133; SMP1_000107; Lopac0_000405; doxycycline; LS-187766; Supracyclin; BCBcMAP01_000024; AC1NQXW7; CID5463943; Doxivetin; Doxycycline (200mg/day) or Placebo; SPBio_002784; Doxycycline hyclate; Monodox; Spectrum5_000947; Doxiciclina; KBio2_003855; Apo-Doxy; 24390-14-5; HMS2090E06; BSPBio_001936; Vibramycin; Doxy-Puren; Doxytec; DB00254; Prestwick3_000852; Liviatin; Prestwick2_000852; NCGC00179395-01; CID5281011; DOXCYCLINE ANHYDROUS; Doxytetracycline; (2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; Doxycycline (anhydrous); 6-Deoxytetracycline; 6alpha-Deoxy-5-oxytetracycline; Azudoxat; Vibravenos; DOXYCYCLINE CALCIUM; BMY-28689; NINDS_000345; Prestwick0_000852; Doxychel (TN); 69935-17-7 (mono-hydrochloride, di-hydrate); NCGC00161602-01; Doxiciclina [INN-Spanish]; (2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; Vivox (*Hyclate); EINECS 209-271-1; KBio1_000345; LS-93868; 564-25-0; 7164-70-7; DMSC (*Fosfatex); Spectrum_000807; KBio2_001287; HSDB 3071; Oracea; Doxychel; 6-alpha-Deoxy-5-oxytetracycline; Doxycycline anhydrous; (2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; Doxysol; CID6713981; Jenacyclin; UPCMLD-DP021:001; BIDD:GT0146; Novo-Doxylin; C06973; Doxy-Caps; Deoxymykoin; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS); Doxycen; Ronaxan; STOCK1N-34341; alpha-6-Deoxyoxytetracycline; BU-3839T; 5-Hydroxy-alpha-6-deoxytetracycline; Alti-Doxycycline; Doxycycline (internal use); Vibra-tabs; NCGC00167961-01; 10597-92-9; NCGC00161602-03; CID5353597; IDI1_000345; GS-3065 (*monohydrate); KBio2_006423; BSPBio_000863; alpha-6-Deoxy-5-hydroxytetracycline; Doxycyclinum [INN-Latin]; Spectrum3_000408; Dossiciclina [DCIT]; BPBio1_000951; Doxycin; Doxiciclina [Italian]; Vibramycine; KBioSS_001287; Doxycycline-Chinoin; 2-Naphthacenecarboxamide, 4-alpha-S-(dimethylamino)-1,4,4a-alpha-5,5a-alpha,6,11,12a-octahydro-3,5-alpha,10,12,12a-alpha-pentahydroxy-6-alpha-methyl-1,11-dioxo-; SPBio_000246; Vibramycin (*monohydrate); AB08 (*Fosfatex); Dossiciclina; KBio3_001156; CHEMBL1433; Investin; Oxytetracycline, 6-deoxy-; UPCMLD-DP021; MolPort-002-507-423; D07876; Doxycycline (TN); Prestwick1_000852; 41411-66-9 (6-epimer, mono-hydrochloride); Atridox; AC1NS4CW; Doxy-Tabs; AC1NUYS8; CPD001550033; DOXY; UNII-334895S862; NCGC00161602-04; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))-; (2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; Monodox (*monohydrate); (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide; 17086-28-1 (mono-hydrate); Spectrum4_000527; Spanor; SAM002589932; Nu-Doxycycline
Trade NamePeriostat
CompanyCollagenex
IndicationAdvanced gum disease, chronic periodontitis
[ICD9: 523.4, 523.5   ICD10: K05.3, K05.4]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAntiinflammatory
CAS NumberCAS 564-25-0
FormulaC22H24N2O8
PubChem Compound IDCID 5281011.
PubChem Substance IDSID 9187.
ChEBI50845;
SuperDrug ATC IDA01AB22; J01AA02
SuperDrug CAS ID000564250;
TargetMMP-8Inhibitor[2][3][4]
Ref 1How many modes of action should an antibiotic have? Curr Opin Pharmacol. 2008 Oct;8(5):564-73. Epub 2008 Jul 30. To Reference
Ref 216498445
Ref 317199549
Ref 420370419



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543